Central nervous system (CNS) tumors comprise 2% to 5% of all tumors. 80% involve the brain and 20% involve the spinal cord. Brain tumors cause approximately 2% of all cancer deaths. 60% to 80% of brains tumors are primary and rest 20% to 40% are metastatic. 1 Tumors of the CNS account for as many as 20% of all cancers of childhood and are second only to leukaemia as a cause of death from malignancy. In childhood 70% of primary brain tumors are infratenorial and involve cerebellum, midbrain, pons and medulla. 2 Benign tumors of the brain tend to grow slowly and some of them may be cured by surgery with or without radiation therapy. The malignant tumors grow more rapidly and are associated with a shorter survival. Some of those highly lethal tumors, such as medulloblastoma and ependymoblastoma have a tendency to disseminate throughout the CNS.
find out any relationship with the brain tumor. Clinical symptoms and sign in relation to brain tumor were recorded. X ray skull and CT scan reports of all cases were evaluated. To find out the histopathological pattern of the brain tumors all histopathological reports were also evaluated.
Collected data was analyzed by using Statistical Package for Social Science (SPSS version 12.0).
Results:
Among the 50 patient 66% were male and male female ratio was 1.9:1. Mean (+SD) age of the patients were 46±11 years. Seventy percent patients came from rural area and 92% patients were Muslim. Forty eight percent patients from middle socioeconomic background and rest from higher or lower socioeconomic status. There was no difference in socioeconomic status.
Most common symptoms of brain tumors were headache (76%), mental change (46%), Vomiting (52%), visual defect (46%), difficulty in movement (42%) and convulsion (36%). Others symptoms were complete blindness (20%), dementia (14%), unconsciousness (14%), fever (06%), weight gain (06%), anorexia (04%), vertigo (04%), sensory loss (04%) and loss of libido (02%). In most of the cases more than one symptom were present ( Table-I) . Large number of patients had signs of increased intracranial pressure (58%), focal presentation (46%), visual defects (50%), and oculomotor and abducens nerve defects (12%), other signs (less frequent) includes sensory level defects (12), facial palsy (08%), incoordination (06%), endocrine abnormalities (06%), Parinaud's Syndrome (02%). In most of the cases more than one signs were present ( Table-II X ray skull was done in all patients. More than 50% of case there were no radiological findings, 32% cases showed bony lesion and 14% cases showed calcification (Fig 1) . CT was done in all patients and hydrocephalus was detected in 30% patients (Fig 2) Histological examination was done in all patients. 40% patients had astrocytomas. Pituitary tumors and Meningiomas were 16% and 14% respectively. Other tumor types include, Craniopharyngioma (06%), Pineal tumour (08%), Ependymoma (04%), Medulloblastma (04%), Oligodendroglioma (02%), Brain stem tumor (02%), Thalamic tumor (02%) ( Table-III) . 
Discussion:
The present study is a clinicopathological study of brain tumor. Clinical presentation may very according the site and type of brain tumor, although there are some common symptoms, namely, headache, seizure, mental change and sensorimotor defects and any of which can eventually be found in more than 50% of the patient population. Ocular change (e.g. visual defect) is associated with the tumors, like, pituitary adenoma craniopharyngioma optic nerve glioma and pineal growth. Most of the tumors present focal presentation related to tumors location. 5 In this series, 76% of case present headache, 64% mental changes, 52% vomiting, 46% visual defect, 36% convulsion, 20% completely blind.
Physical findings can be variable according to tumor type and location. Common signs are focal presentation related to location of tumor, and increased intracranial pressure (ICP) and abducence and oculomotor nerve defects,. Ocular changes are accompaniment of optic glioma pituitary adenoma and pineal growth. Endocrine abnormalities may be found in case of pituitary adenoma and pineal tumor. 5 In the present series, 58% cases had ICP, 50% visual defects, 46%focal presentation related to tumor location and 32% cases abducence and oculomotor nerve defects.
In this study skull radiography and CT scan were done in all patients. Skull radiography is poor in detecting brain tumour. Intracranial space occupying lesion (ICSOL) was found in all patients. Some degree of hydrocephalus was associated with 30% patients. Biopsy and histopathology were also performed in all patients. In this study astrocytomas were found in 40% of cases, among them 22% are grade II, 10% grade I, 6% grade III and 4% grade IV (glioblastoma multiforme). Pituitary tumors were 16% pineal tumor 6% ependymoma, 4% medulloblastoma 4%, oligodendroglioma 2% and brain stem tumor 2%. Allen and Chutorian found gliomas 50% of all primary brain tumors and glioblastomas comprise over 50% of all glioma, meningioma constitutes 15% of primary intracranial neoplasm. Pituitary adenomas comprise 12% to 18% of intracranial neoplasm, the majority of which are chromo phobic; they are almost never malignant. 3, 6 Walker MD found medulloblastoma represents 4% to 8% of all primary brain tumor and ependymomas account for 1% to 8%. 4 Percentage of gliomas was correlates with the study done by Allen and Chutorian but the grading of the tumor markedly varies and almost reverse. In the previous study it was found that more than 50% of gliomas are in advanced grade, 3 but in this study maximum glioma cases are found in grade I. & II Percentage of pituitary adenoma, meningioma and other tumors well correlate with the previous study.
In conclusion in this study most common manifestation of brain tumor was vomiting, convulsion, headache, visual defect, papilloedema, focal neurological sign, oculomotor and abducens nerve defects. One third of the patient had associated hydrocephalus. Astrocytoma was the common tumor of brain followed by Meningioma and Pineal tumour. Diagnostic yield of x-ray skull is poor. MRI or CT scan should be done in any suspected case of Brain tumour.
